Skip to content

Vitamin E

ALIMENTARY TRACT AND METABOLISM

Also known as: Tocofer 400, tocopherol (vit E)

FDA approvedATC A11HA03

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Vitamin E is a drug catalogued in DrugCentral. It was first approved by the FDA in 1953. DrugCentral lists 2 molecular targets, including GSTP1 and TTPA. Recorded indications include Vitamin E deficiency.

  • Molecular targets: GSTP1 and TTPA (2 listed in DrugCentral).
  • Indications: Vitamin E deficiency.
  • ATC code: A11HA03 (Other plain vitamin preparations).

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Vitamin E deficiency

Mechanism & targets

Molecular targets (2)

TargetGeneActionActivity
Glutathione S-transferase PGSTP1unknownIC50 6.30
Alpha-tocopherol transfer proteinTTPAunknownKd 5.62

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1953-02-20FDA—HOSPIRA

ATC classification

ATC codeTherapeutic hierarchy
A11HA03ALIMENTARY TRACT AND METABOLISM › VITAMINS › OTHER PLAIN VITAMIN PREPARATIONS › Other plain vitamin preparations

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Vitamin E is on its molecule page.

Molecular formula—
Molecular weight—
CAS number—
InChIKey—
PubChem CID14985

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Vitamin E used for?

DrugCentral lists the following indications for Vitamin E: Vitamin E deficiency.

How does Vitamin E work?

Its molecular targets in DrugCentral include GSTP1 and TTPA.

When was Vitamin E first approved?

Vitamin E was first approved by the FDA in 1953.

Browse: all drugs starting with V · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval1953-02-20
AgencyFDA
Targets2
Indications1
Formula—
DrugCentral ID3613
Interactive profile